Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants

Confronted with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, such as Delta and Omicron, with high infectivity and immune evasion capacity, vaccination remains the most effective tool to prevent infection and severe illness. However, heterologous vaccination of mRNA vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Chun-Hsiang, Chang, Yu-Hsiu, Tao, Chi-Wei, Chang, Feng-Yee, Chiu, Kuo-Chou, Chang, Tien-Wei, Yen, Li-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602831/
https://www.ncbi.nlm.nih.gov/pubmed/36005765
http://dx.doi.org/10.1128/spectrum.00609-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602831/
https://www.ncbi.nlm.nih.gov/pubmed/36005765
http://dx.doi.org/10.1128/spectrum.00609-22

Ejemplares similares